Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

UBS Analyst Reaffirms Neutral Rating on Ross Stores with Increased Price Target

Elaine Mendonca by Elaine Mendonca
March 6, 2024
in Breaking News
0
Food Retailers Stock Market Today
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

UBS analyst Jay Sole has reaffirmed Ross Stores (NASDAQ: ROST) with a Neutral rating and increased the price target to $145 on March 6, 2024. This adjustment reflects UBS’s thorough analysis of Ross Stores’ performance and potential in the market. UBS is known for its cutting-edge investment research provided through UBS Neo, offering valuable insights supported by primary evidence to aid investors in making well-informed decisions.

The Chief Investment Office (CIO) at UBS focuses on delivering investment insights to assist clients in making intelligent portfolio decisions. UBS Group AG, the parent company of UBS, operates on a global scale across various financial sectors, including Global Wealth Management, Personal & Corporate Banking, Asset Management, and Investment Bank.

UBS’s recent acquisition of Credit Suisse has had a significant impact on its market position and financial performance. The merger has bolstered UBS’s asset management capabilities and positioned it as a leader in key markets such as Asia and EMEA. This strategic move has resulted in record profits for UBS, demonstrating its strengthened financial standing.

Despite the optimistic outlook post-acquisition, UBS faces challenges such as integrating with Credit Suisse, navigating market fluctuations, and managing internal adjustments like job cuts and integration costs. Nevertheless, UBS’s forward-thinking strategy, operational efficiencies, and positive market sentiment place it in a strong position for sustained growth and success in the financial industry.

ROST Stock Sees Slight Decrease on March 6, 2024 but Remains Strong Near 52-Week High

On March 6, 2024, ROST stock experienced a slight decrease in value, trading near the top of its 52-week range and above its 200-day simple moving average. The stock opened at $144.30, which was $4.87 lower than its previous close. Throughout the trading day, the price of ROST shares dropped by $1.60, representing a 1.07% decrease from the previous day’s closing price.

Despite the slight decrease in value on March 6, ROST stock has been performing well overall, trading near the top of its 52-week range. This indicates that investors have confidence in the company’s performance and future prospects. Additionally, the fact that ROST is trading above its 200-day simple moving average suggests that the stock has been on an upward trend in the long term.

Ross Stores, Inc. (ROST) Stock Performance Analysis: Revenue and Net Income Flat, EPS Decreases

On March 6, 2024, Ross Stores, Inc. (ROST) stock performance was under scrutiny as investors analyzed the company’s financial data. According to CNN Money, Ross Stores reported a total revenue of $18.70 billion for the past year, which remained flat compared to the previous year. The total revenue for the third quarter was $4.92 billion, which also held flat since the previous quarter.

In terms of net income, Ross Stores reported $1.51 billion for the past year, representing a 12.22% decrease compared to the previous year. The net income for the third quarter was $447.33 million, which held flat since the previous quarter.

Earnings per share (EPS) for Ross Stores were reported at $4.38 for the past year, showing a 10.06% decrease compared to the previous year. The EPS for the third quarter was $1.33, which also held flat since the previous quarter.

Tags: ROST
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
IT-Healthcare

Analysts Remain Bullish on McKesson with Increased Price Target

Healthcare-and-IT

Neptune Wellness Solutions Faces Delisting from Nasdaq Looks to OTCQB Market

Fiances and technology

The Threat of AIGenerated Election Disinformation

Recommended

SKYX Platforms Stock

Marriott Partnership Signals Major Breakthrough for SKYX Platforms

5 months ago
Microsoft Stock

Microsoft’s AI Ambition: A High-Stakes Bet on Future Growth

18 hours ago
Turtle Beach Stock

Turtle Beach Forges PlayStation Alliance with New Gaming Headset

5 months ago
FLO stock news

Cemtrex Shares Surge After Halting Trading Due to Circuit Breaker

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

CureVac Delisted Following BioNTech Acquisition Completion

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

Fossil Group Stock Surges Past Key Technical Threshold

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

Trending

Rolls Royce Stock
Defense & Aerospace

Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

by Dieter Jaworski
February 5, 2026
0

The coming weeks represent a critical juncture for Rolls-Royce. The company is poised to demonstrate whether it...

Viking Therapeutics Stock

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

February 5, 2026
Solana Stock

Solana Faces Billions in Potential Token Supply Releases

February 5, 2026
CureVac Stock

CureVac Delisted Following BioNTech Acquisition Completion

February 5, 2026
EOS Stock

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

February 5, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Rolls-Royce Shares: A Pivotal Period for Growth and Diversification
  • Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report
  • Solana Faces Billions in Potential Token Supply Releases

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com